Related Experiment Videos
Bronchial fenestration improves expiratory flow in emphysematous human lungs
Henning F Lausberg1, Kimiaki Chino, G Alexander Patterson
1Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, Missouri, USA.
The Annals of Thoracic Surgery
|February 28, 2003
Summary
Bronchopulmonary stents can improve expiratory flow in emphysema patients by reducing dynamic hyperinflation. This novel technique creates passages to enhance lung function and ease breathing difficulties.
Area of Science:
- Pulmonary Medicine
- Biomedical Engineering
- Respiratory Physiology
Background:
- Emphysema causes dynamic hyperinflation, increasing breathing work and dyspnea.
- Collateral ventilation in emphysematous lungs presents a therapeutic target.
- Altered respiratory mechanics in emphysema necessitate innovative treatment strategies.
Purpose of the Study:
- To investigate the efficacy of bronchopulmonary stents in reducing dynamic hyperinflation.
- To assess the impact of stent placement on expiratory flow in emphysematous lungs.
- To explore a novel therapeutic approach for severe emphysema.
Main Methods:
- Human emphysematous lungs were utilized in a controlled ventilation chamber.
- A radiofrequency catheter created passages between segmental bronchi and lung parenchyma.
- Expandable bronchopulmonary stents were inserted, and expiratory volumes were measured.
Main Results:
- Placement of three stents significantly increased forced expiratory volume in 1 second (FEV1) from 245 mL to 447 mL (p < 0.001).
- Adding two more stents further elevated FEV1 to 666 mL (p < 0.001).
- The study demonstrated a dose-dependent improvement in expiratory volume with stent insertion.
Conclusions:
- Creating extra-anatomic bronchopulmonary passages via stenting is a viable therapeutic option.
- This approach shows promise for emphysematous patients with severe hyperinflation and lung destruction.
- Bronchopulmonary stenting may offer a new avenue for managing emphysema complications.